<?xml version="1.0" encoding="UTF-8"?>
<!--Generated by Squarespace Site Server v5.0.0 (http://www.squarespace.com/) on Wed, 07 Jan 2009 01:21:18 GMT--><rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:rss="http://purl.org/rss/1.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:sy="http://purl.org/rss/1.0/modules/syndication/" xmlns:admin="http://webns.net/mvcb/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:cc="http://web.resource.org/cc/"><rss:channel rdf:about="http://brainscienceblogs.com/drug-disposition-pharmacokine/"><rss:title>Drug Disposition &amp; Pharmacokinetics</rss:title><rss:link>http://brainscienceblogs.com/drug-disposition-pharmacokine/</rss:link><rss:description></rss:description><dc:language>en-US</dc:language><dc:date>2009-01-07T01:21:18Z</dc:date><admin:generatorAgent rdf:resource="http://www.squarespace.com/">Squarespace Site Server v5.0.0 (http://www.squarespace.com/)</admin:generatorAgent><rss:items><rdf:Seq><rdf:li rdf:resource="http://brainscienceblogs.com/drug-disposition-pharmacokine/2008/3/25/drug-disposition-pharmacokinetics.html"/></rdf:Seq></rss:items></rss:channel><rss:item rdf:about="http://brainscienceblogs.com/drug-disposition-pharmacokine/2008/3/25/drug-disposition-pharmacokinetics.html"><rss:title>Drug Disposition &amp; Pharmacokinetics</rss:title><rss:link>http://brainscienceblogs.com/drug-disposition-pharmacokine/2008/3/25/drug-disposition-pharmacokinetics.html</rss:link><dc:creator>Contacts</dc:creator><dc:date>2008-03-25T21:31:45Z</dc:date><dc:subject>Drug Disposition &amp; Pharmacokinetics</dc:subject><content:encoded><![CDATA[<p><a href="http://www.medworksmedia.com/psychopharmbulletin/index.php" target="_blank">Switching from Other Agents to Extended-Release Carbamazepine in Acute Mania<br />By Rif S. El-Mallakh, MD, Terence A. Ketter, MD, Richard H. Weisler, MD, Robert Hirschfeld, MD, Andrew J. Cutler, MD, Thomas Gazda, MD, Paul Keck, Jr, MD, Alan C. Swann, MD, and Amir H. Kalali, MD</a></p><p><a target="_blank" href="http://www.medworksmedia.com/psychopharmbulletin/index_archives.php?id=22">The Effect of Food on the Absorption of Oral Ziprasidone<br />By Jeffrey J. Miceli, PhD, Paul Glue, MD, PhD, Jeffrey Alderman, PhD, and Keith Wilner, PhD </a><br /></p><p><a href="http://www.medworksmedia.com/psychopharmbulletin/index_archives.php?id=21" target="_blank">Long-Acting Injectable Risperidone in the Treatment of Schizophrenia in Special Patient Populations<br />By Eduard Parellada, MD, MSc, PhD</a></p><p><a target="_blank" href="http://www.medworksmedia.com/psychopharmbulletin/index_archives.php?id=20">Drug&ndash;Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients<br />Robert R. Conley, MD and Deanna L. Kelly, PharmD, BCPP </a></p><p><a href="http://www.medworksmedia.com/psychopharmbulletin/index_archives.php?id=18" target="_blank">Efficacy of Olanzapine and Risperidone in Schizophrenia:A Randomized Double-Blind Crossover Design<br />By Jose M. Canive, MD, Gregory A Miller, PhD, Jessica G. Irwin, BS, Sandra N. Moses, PhD, Robert J. Thoma, PhD, J. Christopher Edgar, PhD, <br />Andrea Sherwood, PhD, Fernando Torres, MD, Marianna LaNoue, PhD,&nbsp; Stephen Lewis, MD, Faith M. Hanlon, PhD, Michael P. Weisend, PhD, <br />Valerie Mead, MD, and Vicente B. Tuason, MD</a> </p><p>&nbsp;</p><a href="http://www.medworksmedia.com/psychopharmbulletin/index_archives.php?id=21" target="_blank"></a>
]]></content:encoded></rss:item></rdf:RDF>